www.hermespardini.com.br 1
importante citar que elevaes da cistatina C, sem correlao com diminuio da TFG, foram descritas em pacientes com o mieloma mltiplo, tumores malignos, cirrose heptica, e alguns hipertensos com proteinria. Deve-se interpretar com cautela os nveis de cistatina C nestes pacientes, correlacionado com a creatinina e seu clearance (23,24,25,26,27,28,29).
O Instituto de Patologia Clnica Hermes Pardini realiza a determinao da Cistatina C : Mtodo: nefelometria Amostra: sangue Valores de referncia: Recem nascidos: 1,37 a 1,89 mg/l 1 ms a 12 meses: 0,73 a 1,17 mg/l Maiores de 1 ano: 0,53 a 0,95 mg/l
13.
14.
15.
19.
Bibliografia
1.
2. 20. Kasiske BL, William FK. Laboratory assessment of renal disease. In: Brenner BM. The kidney, 6th. Philadelphia. WB Saunders Company. 2000: 1130-42. Bostom AG, Dworkin LD. Cystatin C measurement: improved detection of mild decrements in glomerular filtration rate versus creatinine-based estimates? Am J Kidney Dis. 2000; 36: 205-7. Swaminathan R. Cystatin for estimation of glomerular filtration rate. Lancet. 2001; 357: 143. Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A et al. Serum Cystatin C. Am J Kidney Dis. 2000; 36: 29-34. Randers E, Erlandsen EJ, Pedersen OL, Hasling C, Danielsen H. Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired Kidney function. Clin. Nephrol. 2000; 54: 203-9. Steven LA, Coresh J, Greene T, Levey AS. Assessing Kidney Function Measured and Estimated Glomerular Filtration Rate. N Engl J Med . 2006; 354: 2473-83. Stevens L, Perrone RD. Assesment of kidney function: Serum creatinine; BUN; and GFR. Disponvel em: <http://www.utdol.com/utd/content/topicKey=fldlytes/3211 0&view=text. Acesso em: 7 fev. 2007. Stevens LA, Levey AS. Measurement of Kidney Function. Med Clin N Am. 2005; 89: 457-73. Shlipak MG et al. Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med. 2005; 118: 1416.e251416.e31. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis. 2001; 37: 79-83. Meier P, Froidevaux C. Cystatin C concentration and glomerular rate. Lancet. 2001; 357: 634-5. Tomino Y, Suzuki S, Gohda T, Kobayashi M, Horikoshi S, Imai H. Serum cystatin C may predict the prognostic stages of patient with IgA nephropathy prior renal biopsy. J Clin Lab Anal. 2001; 15: 25-29.
21.
3. 4. 5.
22.
23. 24.
6. 7.
25. 26.
8. 9.
10. 11. 12.
27.
28. 29.
Stowe H, Lawrence D, Newman D, Lamb E. Analytical performance of a particle-enhanced nephelometric immunoassay for serum cystatin C using rate analysis. Clin Chem. 2001; 47: 1482-5. Mojiminniyi OA, Abdella N, George S. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus. Scand J Clin Lab Invest. 2000; 60: 483-9. Herget-Rosenthal S, trabold S, Pietruck F, Holtmann M, Phillip T, Kribben A. Cystatin C: efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol. 2000; 20: 97-102. Finney H. Newmann DJ, Price CP. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 2000; 37: 49-59. Randers E, Kristensen JH, Erlandsen EJ, Danielsen H. Serum cystatin C as a marker of the renal function. Scand J Clin Lab Invest. 1998; 58: 585-92. Le Bricon T, Thervet E. Benlakehal M, Bousquet B, Legendre C, Erlich D. Changes in plasma cystatin C after renal transplantation and acute rejection in adults. Clin Chem. 2000; 46: 1206-7. Plebani M, Dall`Amico R, Mussap M, Montini, Ruzzante N, Marsilio R, Giordano G, Zacchello G. Is serum cystatin C a sensitive marker of glomerular filtration rate ? A preliminary study on renal transplant patients. Ren Fail. 1998; 20: 303-9. Rish L, Blumberg A, Huber AR. Assessment of renal failure function in renal trnasplant patients us cystatin C. A comparison to other function markers a estimates. Ren Fail. 2001. May; 23: 439-48. Kasiske BL, Vasquez MA, Harmon WE, Brown RS, et al. Recomendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol. 2000; 11: S1-86. Shlipak MG et al. Cystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons. N Engl J Med. 2005; 352: 2049-60. Finney H, Williams AH, Price CP. Serum cystatin C in patients with myeloma. Clin Chim Acta. 2001; 309: 1-6. Takeuchi M, Fukuda Y, Katano Y, Hayakawa T. Elevation of serum cystatin C concentration in patients wtih chronic liver disease. Eur J Gastroenterol Hepatol. 2001. Aug; 13: 951-955. Zitta S, Auprich M. Cystatin C concentration and glomerular rate. Lancet. 2001; 357: 634-5. Harmoinen AP, Kouri TT, Wirta OR, Lehtimaki TJ, Rantalaiho V, Turjanma VM, Pasternack AI. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes. Clin Nephrol. 1999; 52: 363-70. Herget-Rosenthal S, Trabold S, Huesing J, Heemann U, Philipp T, Kribben A . Cystatin C na accurate marker of glomerular filtration rate after renal transplantation? Transp Int 2000; 13: 285-9. Page MK, Bukki J. Luppa P, Neumeier D. Clinical value of cystatin C determination. Clin. Chim. Acta. 2000; 297: 6772. Donatio C, Luchesi A . Serum cystatin as a marker of glomerular filtration rate. Am J Kidney Dis. 2001; 37: 44851.
www.hermespardini.com.br 2